Qingdao Baheal Medical INC. (SHE:301015)

SHE:301015 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Market Capitalization	12,604	12,725	18,830	12,518	15,911	-
Market Cap Growth	4.35%	-32.42%	50.42%	-21.32%	-	-
Enterprise Value	14,028	13,693	19,206	12,782	15,944	-
Last Close Price	23.98	23.21	33.53	21.70	26.72	-
PE Ratio	24.73	18.40	26.44	24.93	37.74	-
Forward PE	20.85	13.27	25.05	21.53	33.48	-
PS Ratio	1.66	1.57	2.28	1.67	2.26	-
PB Ratio	4.56	4.89	6.04	5.49	7.32	-
P/TBV Ratio	5.89	6.25	7.12	5.58	7.50	-
P/FCF Ratio	22.18	24.96	30.67	62.46	103.45	-
P/OCF Ratio	14.44	15.64	23.55	40.94	87.76	-
EV/Sales Ratio	1.85	1.69	2.33	1.70	2.26	-
EV/EBITDA Ratio	16.22	13.25	17.30	17.37	25.05	-
EV/EBIT Ratio	17.64	13.95	18.25	17.94	25.94	-
EV/FCF Ratio	24.68	26.86	31.28	63.77	103.66	-
Debt / Equity Ratio	1.16	0.92	0.47	0.59	0.56	0.90
Debt / EBITDA Ratio	3.70	2.26	1.28	1.74	1.87	3.12
Debt / FCF Ratio	5.63	4.68	2.37	6.67	7.97	-
Asset Turnover	1.05	1.20	1.44	1.56	1.64	1.58
Inventory Turnover	5.68	5.84	7.28	8.52	8.55	8.05
Quick Ratio	1.18	1.19	1.69	1.29	1.38	1.13
Current Ratio	1.55	1.57	2.14	1.64	1.70	1.42
Return on Equity (ROE)	24.14%	26.80%	28.55%	21.80%	22.60%	19.77%
Return on Assets (ROA)	6.86%	9.07%	11.49%	9.25%	8.93%	6.96%
Return on Invested Capital (ROIC)	17.70%	23.33%	27.47%	22.37%	23.81%	20.53%
Return on Capital Employed (ROCE)	19.20%	25.50%	26.10%	29.40%	27.90%	27.50%
Earnings Yield	4.18%	5.44%	3.78%	4.01%	2.65%	-
FCF Yield	4.51%	4.01%	3.26%	1.60%	0.97%	-
Dividend Yield	3.18%	3.28%	-	3.51%	2.50%	-
Payout Ratio	87.88%	65.05%	61.81%	80.11%	13.22%	54.61%
Buyback Yield / Dilution	0.31%	-0.92%	-2.37%	-5.44%	-5.50%	0.49%
Total Shareholder Return	3.49%	2.36%	-2.37%	-1.92%	-3.00%	0.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.